| Filed On | Filing |
|---|---|
| 22 Oct 2026 | 25-NSE |
| 13 Oct 2026 |
8-K: Other Events
Fast Track designation recognizes the potential of SAB-142 to address an unmet medical need for people with Stage 3 type 1 diabetes |
| 18 Sep 2026 |
Form 4: Kropotova Alexandra, CHIEF MEDICAL OFFICER
Gave up 473 shares to cover exercise price or tax |
| 21 Aug 2026 | 424B3 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | SCHEDULE 13G |
| 10 Aug 2026 | SCHEDULE 13D/A |
| 06 Aug 2026 | 10-Q |
| 07 Jul 2026 | 8-K: Regulation FD Disclosure |
| 26 Jun 2026 |
Form 4: Kropotova Alexandra, CHIEF MEDICAL OFFICER
Gave up 988 shares to cover exercise price or tax |
| 18 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 15 May 2026 | SCHEDULE 13G/A |
| 15 May 2026 | SCHEDULE 13G |
| 15 May 2026 | SCHEDULE 13G |
| 12 May 2026 | 10-Q |
Loading...
